238 related articles for article (PubMed ID: 27168100)
1. Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy.
Luizon MR; Palei ACT; Belo VA; Amaral LM; Lacchini R; Duarte G; Cavalli RC; Sandrim VC; Tanus-Santos JE
Pharmacogenomics J; 2017 Oct; 17(5):427-434. PubMed ID: 27168100
[TBL] [Abstract][Full Text] [Related]
2. Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy.
Luizon MR; Belo VA; Palei AC; Amaral LM; Lacchini R; Sandrim VC; Duarte G; Cavalli RC; Tanus-Santos JE
Hypertens Res; 2015 May; 38(5):361-6. PubMed ID: 25716650
[TBL] [Abstract][Full Text] [Related]
3.
Pereira DA; Sandrim VC; Palei AC; Amaral LM; Belo VA; Lacchini R; Cavalli RC; Tanus-Santos JE; Luizon MR
Pharmacogenomics; 2021 Jun; 22(8):451-464. PubMed ID: 33944612
[No Abstract] [Full Text] [Related]
4. The effects of NAMPT haplotypes and metabolic risk factors on circulating visfatin/NAMPT levels in childhood obesity.
Belo VA; Luizon MR; Lacchini R; Miranda JA; Lanna CM; Souza-Costa DC; Tanus-Santos JE
Int J Obes (Lond); 2015 Jan; 39(1):130-5. PubMed ID: 24100423
[TBL] [Abstract][Full Text] [Related]
5. Effects of matrix metalloproteinase (MMP)-2 polymorphisms on responsiveness to antihypertensive therapy of women with hypertensive disorders of pregnancy.
Palei AC; Sandrim VC; Amaral LM; Machado JS; Cavalli RC; Lacchini R; Duarte G; Tanus-Santos JE
Basic Clin Pharmacol Toxicol; 2012 Oct; 111(4):262-7. PubMed ID: 22672240
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy.
Palei AC; Sandrim VC; Amaral LM; Machado JS; Cavalli RC; Lacchini R; Duarte G; Tanus-Santos JE
Pharmacogenomics J; 2012 Dec; 12(6):489-98. PubMed ID: 21769110
[TBL] [Abstract][Full Text] [Related]
7. Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy.
Luizon MR; Palei AC; Sandrim VC; Amaral LM; Machado JS; Lacchini R; Cavalli RC; Duarte G; Tanus-Santos JE
Pharmacogenomics J; 2014 Dec; 14(6):535-41. PubMed ID: 24913092
[TBL] [Abstract][Full Text] [Related]
8. eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestational hypertension.
Sandrim VC; Palei AC; Luizon MR; Izidoro-Toledo TC; Cavalli RC; Tanus-Santos JE
Pharmacogenomics J; 2010 Feb; 10(1):40-5. PubMed ID: 19704415
[TBL] [Abstract][Full Text] [Related]
9. Association between matrix metalloproteinase (MMP)-2 polymorphisms and MMP-2 levels in hypertensive disorders of pregnancy.
Palei AC; Sandrim VC; Amaral LM; Machado JS; Cavalli RC; Duarte G; Tanus-Santos JE
Exp Mol Pathol; 2012 Apr; 92(2):217-21. PubMed ID: 22327101
[TBL] [Abstract][Full Text] [Related]
10. The interplay between extracellular NAMPT and inflammatory cytokines in preeclampsia.
Nunes PR; Pereira DA; Passeti LFP; Coura LLF; Gomes KB; Sandrim VC; Luizon MR
J Reprod Immunol; 2024 Jun; 163():104248. PubMed ID: 38703439
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal Study of Plasma Visfatin/Nicotinamide Phosphoribosyltransferase (NAMPT) Levels in Healthy Pregnant Women.
Nunes PR; Cavalli RC; Belo VA; Sandrim VC; Luizon MR
Reprod Sci; 2023 Oct; 30(10):2893-2895. PubMed ID: 37118060
[TBL] [Abstract][Full Text] [Related]
12. Plasma visfatin/nicotinamide phosphoribosyltransferase levels in hypertensive elderly - results from the PolSenior substudy.
Kocelak P; Olszanecka-Glinianowicz M; Owczarek A; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Zdrojewski T; Grodzicki T; Więcek A; Chudek J
J Am Soc Hypertens; 2015 Jan; 9(1):1-8. PubMed ID: 25537462
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics in the treatment of pre-eclampsia: current findings, challenges and perspectives.
Luizon MR; Palei AC; Cavalli RC; Sandrim VC
Pharmacogenomics; 2017 Apr; 18(6):571-583. PubMed ID: 28358601
[TBL] [Abstract][Full Text] [Related]
14. NAMPT levels are inversely related to nitric oxide formation and positively related to soluble fms-like tyrosine kinase-1 levels in preeclampsia.
Pereira DA; Sandrim VC; Palei ACT; Tanus-Santos JE; Belo VA; Cavalli RC; Luizon MR
Pregnancy Hypertens; 2019 Oct; 18():137-140. PubMed ID: 31610400
[TBL] [Abstract][Full Text] [Related]
15. Visfatin -948G/T and resistin -420C/G polymorphisms in Egyptian type 2 diabetic patients with and without cardiovascular diseases.
Motawi TM; Shaker OG; El-Sawalhi MM; Abdel-Nasser ZM
Genome; 2014 May; 57(5):259-66. PubMed ID: 25120107
[TBL] [Abstract][Full Text] [Related]
16. Plasma visfatin levels in preeclamptic and normal pregnancies.
Zulfikaroglu E; Isman F; Payasli A; Kilic S; Kucur M; Danisman N
Arch Gynecol Obstet; 2010 Jun; 281(6):995-8. PubMed ID: 19639329
[TBL] [Abstract][Full Text] [Related]
17. The role of visfatin (PBEF/Nampt) in pregnancy complications.
Pavlová T; Novák J; Bienertová-Vašků J
J Reprod Immunol; 2015 Nov; 112():102-10. PubMed ID: 26451650
[TBL] [Abstract][Full Text] [Related]
18. Association of Nicotinamide Phosphoribosyltransferase (NAMPT) Gene Polymorphisms and of Serum NAMPT Levels with Dilated Cardiomyopathy in a Chinese Population.
Dou Q; Peng Y; Zhou B; Zhang K; Lin J; Dai X; Zhang L; Rao L
Int J Mol Sci; 2015 Sep; 16(9):22299-318. PubMed ID: 26389889
[TBL] [Abstract][Full Text] [Related]
19. The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling.
Owczarek AJ; Olszanecka-Glinianowicz M; Kocełak P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Puzianowska-Kuźnicka M; Grodzicki T; Więcek A; Chudek J
Scand J Clin Lab Invest; 2016 Dec; 76(8):632-640. PubMed ID: 27712122
[TBL] [Abstract][Full Text] [Related]
20. [Genetic variants of endothelial nitric synthase in gestational hypertension and preeclampsia].
Perlik M; Seremak-Mrozikiewicz A; Barlik M; Kurzawińska G; Kraśnik W; Drews K
Ginekol Pol; 2012 Sep; 83(9):652-9. PubMed ID: 23342892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
